Abstract Dopamine (DA, 3-hydroxytyramine) is a member of the catecholamine family and is
classically characterized according to its role in the central nervous system as a …

Pituitary tumors (PT) represent in, the majority of cases, benign tumors for which surgical
treatment still remains, except for prolactin-secreting PT, the first-line therapeutic option …

Bone diseases, for example, osteoporosis, cause excessive differentiation of osteoclasts
and decreased bone formation, resulting in imbalance of bone remodeling and poor …

Purpose: Somatostatin analogues (SSA) are efficacious and safe treatments for a variety of
neuroendocrine tumors, especially pituitary neuroendocrine tumors (PitNET). Their …

Background Osteogenic differentiation of bone mesenchymal stem cells (BMSCs) is
regulated by numerous signaling pathways. Dopamine (DA), a neurotransmitter, has …

It has been well recognized that prolactin (PRL), a pleiotropic hormone, has many functions
in the brain, such as maternal behavior, neurogenesis, and neuronal plasticity, among …

Dopamine agonists such as bromocriptine and cabergoline are the predominant treatment
drugs for prolactinoma by inhibiting prolactin secretion and shrinking tumor size. However …

Abstract Cushing's Syndrome (CS), or chronic endogenous hypercortisolism, is a rare and
serious disease due to corticotroph pituitary (Cushing's disease, CD) and extra-pituitary …

Abstract Context Pituitary neuroendocrine tumors (PitNETs) are a commonly underestimated
pathology in terms of incidence and associated morbimortality. Currently, an appreciable …

Pituitary neuroendocrine tumors (PitNET) are commonly benign tumors accounting for 10-
25% of intracranial tumors. Prolactin-secreting adenomas represent the most predominant …